Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
126 | 4166 | 31.3 | 89% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
11 | 38152 | PERCUTANEOUS CORONARY INTERVENTION//DRUG ELUTING STENT//CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DRUG ELUTING STENT | Author keyword | 405 | 48% | 15% | 613 |
2 | DRUG ELUTING STENTS | Author keyword | 260 | 40% | 12% | 501 |
3 | STENT THROMBOSIS | Author keyword | 157 | 45% | 6% | 266 |
4 | SIROLIMUS ELUTING STENT | Author keyword | 107 | 57% | 3% | 126 |
5 | RESTENOSIS | Author keyword | 86 | 13% | 15% | 607 |
6 | BARE METAL STENT | Author keyword | 76 | 51% | 3% | 107 |
7 | EUROINTERVENTION | Journal | 73 | 25% | 6% | 251 |
8 | EVEROLIMUS ELUTING STENT | Author keyword | 73 | 74% | 1% | 54 |
9 | ZOTAROLIMUS | Author keyword | 63 | 77% | 1% | 43 |
10 | STENTS | Author keyword | 56 | 12% | 11% | 455 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DRUG ELUTING STENT | 405 | 48% | 15% | 613 | Search DRUG+ELUTING+STENT | Search DRUG+ELUTING+STENT |
2 | DRUG ELUTING STENTS | 260 | 40% | 12% | 501 | Search DRUG+ELUTING+STENTS | Search DRUG+ELUTING+STENTS |
3 | STENT THROMBOSIS | 157 | 45% | 6% | 266 | Search STENT+THROMBOSIS | Search STENT+THROMBOSIS |
4 | SIROLIMUS ELUTING STENT | 107 | 57% | 3% | 126 | Search SIROLIMUS+ELUTING+STENT | Search SIROLIMUS+ELUTING+STENT |
5 | RESTENOSIS | 86 | 13% | 15% | 607 | Search RESTENOSIS | Search RESTENOSIS |
6 | BARE METAL STENT | 76 | 51% | 3% | 107 | Search BARE+METAL+STENT | Search BARE+METAL+STENT |
7 | EVEROLIMUS ELUTING STENT | 73 | 74% | 1% | 54 | Search EVEROLIMUS+ELUTING+STENT | Search EVEROLIMUS+ELUTING+STENT |
8 | ZOTAROLIMUS | 63 | 77% | 1% | 43 | Search ZOTAROLIMUS | Search ZOTAROLIMUS |
9 | STENTS | 56 | 12% | 11% | 455 | Search STENTS | Search STENTS |
10 | ZOTAROLIMUS ELUTING STENT | 55 | 78% | 1% | 36 | Search ZOTAROLIMUS+ELUTING+STENT | Search ZOTAROLIMUS+ELUTING+STENT |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BARE METAL STENTS | 649 | 53% | 21% | 868 |
2 | UNCOATED STENTS | 251 | 79% | 4% | 161 |
3 | NEOINTIMAL COVERAGE | 221 | 82% | 3% | 130 |
4 | RESTENOSIS | 179 | 15% | 26% | 1076 |
5 | STANDARD STENT | 160 | 73% | 3% | 121 |
6 | BARE METAL | 157 | 52% | 5% | 214 |
7 | DURABLE POLYMER | 134 | 86% | 2% | 68 |
8 | LARGE 2 INSTITUTIONAL COHORT | 121 | 80% | 2% | 74 |
9 | SLOW RELEASE | 111 | 41% | 5% | 214 |
10 | DRUG ELUTING STENTS | 107 | 21% | 11% | 448 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EUROINTERVENTION | 73 | 25% | 6% | 251 |
2 | JACC-CARDIOVASCULAR INTERVENTIONS | 45 | 20% | 5% | 198 |
3 | CIRCULATION-CARDIOVASCULAR INTERVENTIONS | 21 | 19% | 2% | 103 |
4 | MINERVA CARDIOANGIOLOGICA | 7 | 14% | 1% | 47 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Drug-Eluting Coronary-Artery Stents | 2013 | 117 | 72 | 76% |
Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk | 2006 | 1185 | 37 | 84% |
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation A Systematic Review and Meta-Analysis of Randomized Controlled Trials | 2015 | 8 | 29 | 83% |
Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents - An observational study of drug-eluting versus bare-metal stents | 2006 | 779 | 33 | 67% |
In-Stent Restenosis in the Drug-Eluting Stent Era | 2010 | 140 | 78 | 88% |
In-Stent Neoatherosclerosis A Final Common Pathway of Late Stent Failure | 2012 | 75 | 35 | 74% |
Coronary Stents Current Status | 2010 | 153 | 305 | 61% |
Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis | 2010 | 105 | 39 | 85% |
Stent Thrombosis With Drug-Eluting Stents Is the Paradigm Shifting? | 2013 | 25 | 37 | 89% |
Vascular responses to drug eluting stents - Importance of delayed healing | 2007 | 391 | 57 | 75% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARDIOVASC TECHNOL | 23 | 65% | 0.5% | 22 |
2 | SEVERANCE CARDIOVASC HOSP | 20 | 27% | 1.5% | 63 |
3 | INTERVENT CARDIOL | 19 | 12% | 3.5% | 146 |
4 | ST JOSEPHS TRANSLAT | 17 | 75% | 0.3% | 12 |
5 | CARDIOVASC FDN | 16 | 23% | 1.5% | 61 |
6 | DEUT HERZZENTRUM | 14 | 19% | 1.6% | 68 |
7 | INTERVENT CARDIOL UNIT | 14 | 19% | 1.6% | 67 |
8 | SKIRBALL CARDIOVASC | 13 | 44% | 0.5% | 22 |
9 | CARDIAC VASC NO MICHIGAN | 12 | 86% | 0.1% | 6 |
10 | MERCY ANGIOG UNIT | 10 | 73% | 0.2% | 8 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000168552 | BIFURCATION LESIONS//BIFURCATION LESION//CORONARY BIFURCATION LESIONS |
2 | 0.0000129979 | ROTATIONAL ATHERECTOMY//CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS//ATHERECTOMY |
3 | 0.0000123503 | HMC05//HEBEI PROV PEOPLES HOSP//DIPARTIMENTO CHIRURG GEN PARIDE STEFANINI |
4 | 0.0000118892 | VESSEL SIMULATING FLOW THROUGH CELL//LOCAL PHARMACOKINETICS//PATHOPHARMACOL UNIT |
5 | 0.0000115993 | SYNTAX SCORE//LEFT MAIN//LEFT MAIN CORONARY ARTERY DISEASE |
6 | 0.0000110843 | STENT ARTERY INTERACTION//HYBRID CATHETERIZAT ELE OPHYSIOL//STENT FATIGUE LIFE |
7 | 0.0000102612 | INTRAVASCULAR BRACHYTHERAPY//ENDOVASCULAR BRACHYTHERAPY//VASCULAR BRACHYTHERAPY |
8 | 0.0000069902 | INTRAVASCULAR ULTRASOUND//VIRTUAL HISTOLOGY//VULNERABLE PLAQUE |
9 | 0.0000065636 | LATE BREAKING CLINICAL TRIALS//JAPANESE CIRCULATION SOCIETY//MULTIVESSEL DISEASE |
10 | 0.0000052618 | CHRONIC TOTAL OCCLUSION//CHRONIC TOTAL OCCLUSIONS//RETROGRADE APPROACH |